Form 4: OptimizeRx CEO William Febbo Disposes of Shares to Cover Tax Obligations

OptimizeRx CEO William Febbo disposed of 401 shares of common stock on February 14, 2025, to satisfy tax withholding obligations.

Summary

• On February 14, 2025, William J Febbo, CEO of OptimizeRx Corp, disposed of 401 shares of common stock.
• The transaction was executed to cover the reporting person's tax withholding obligations.
• The price per share was $6.64.
• Following the transaction, Febbo directly owns 600,852 shares of OptimizeRx Corp.
• The filing of this statement should not be construed as an admission that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or that this Statement is legally required to be filed by such person.

Sentiment

Score: 7

Explanation: The sentiment is neutral. The document simply reports a transaction to cover tax obligations, which is a normal occurrence. There is no indication of positive or negative sentiment.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This transaction is related to tax obligations, which is a common reason for stock disposals.

Key Dates

Keywords

OptimizeRx Corp, William Febbo, Form 4, insider trading, stock disposal, tax withholding, OPRX, CEO